Cooper Companies (COO)
Market Price (9/18/2025): $66.0 | Market Cap: $13.2 BilSector: Health Care | Industry: Health Care Supplies
Cooper Companies (COO)
Market Price (9/18/2025): $66.0Market Cap: $13.2 BilSector: Health CareIndustry: Health Care Supplies
Investment Highlights
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 10% | Weak multi-year price returns2Y Excs Rtn is -73%, 3Y Excs Rtn is -80% | Expensive valuation multiplesP/EPrice/Earnings or Price/(Net Income) is 31x |
Low stock price volatilityVol 12M is 34% |
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 10% |
Low stock price volatilityVol 12M is 34% |
Weak multi-year price returns2Y Excs Rtn is -73%, 3Y Excs Rtn is -80% |
Expensive valuation multiplesP/EPrice/Earnings or Price/(Net Income) is 31x |
Market Valuation
9/18/25 | 2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|---|
Share Price CYE | $66.00 | $91.93 | $94.61 | $82.65 | $104.70 |
Market Cap CYE ($ Bil) | 13.2 | 18.3 | 18.8 | 16.4 | 20.6 |
Total Debt ($ Bil) | 2.5 | 2.6 | 2.6 | 2.8 | 1.5 |
Total Cash ($ Bil) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Enterprise Value ($ Bil) | 15.5 | 20.9 | 21.4 | 19.2 | 22.1 |
Valuation Ratios | |||||
P/S TTM | 3.2 | 4.7 | 5.2 | 4.9 | 7.0 |
P/EBIT TTM | 18.2 | 26.2 | 36.1 | 30.6 | 40.0 |
P/E TTM | 32.3 | 46.6 | 63.6 | 42.3 | 7.0 |
Sector Ratios | |||||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 | 4.5 | 7.3 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 | -1.3 | -2.9 |
P/E TTM (Sector) | -1.8 | -1.5 | -1.5 | -1.3 | -2.9 |
9/18/25 | 2024 | 2023 | |
---|---|---|---|
Share Price CYE | $66.00 | $91.93 | $94.61 |
Market Cap CYE ($ Bil) | 13.2 | 18.3 | 18.8 |
Total Debt ($ Bil) | 2.5 | 2.6 | 2.6 |
Total Cash ($ Bil) | 0.1 | 0.1 | 0.1 |
Enterprise Value ($ Bil) | 15.5 | 20.9 | 21.4 |
Valuation Ratios | |||
P/S TTM | 3.2 | 4.7 | 5.2 |
P/EBIT TTM | 18.2 | 26.2 | 36.1 |
P/E TTM | 32.3 | 46.6 | 63.6 |
Sector Ratios | |||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 |
P/E TTM (Sector) | -1.8 | -1.5 | -1.5 |
Business Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Show more
Price Returns Compared
Expand for Detailed View2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
---|---|---|---|---|---|---|---|
Returns | |||||||
COO Return | 13% | 15% | -21% | 14% | -3% | -30% | -17% |
Peers Return | 47% | 28% | -13% | 10% | 0% | 2% | 84% |
S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 12% | 104% |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: JNJ, BSX, REGN, STAA, WST. See COO Returns vs. Peers.
[3] 2025 data is for the year up to 9/17/2025 (YTD)
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Cooper Companies
Financials
Median | |
---|---|
Name | |
Mkt Price | 137.85 |
Mkt Cap | 40.0 |
Rev LTM | 9,130 |
Op Inc LTM | 2,064 |
FCF LTM | 1,823 |
FCF 3Y Avg | 1,240 |
CFO LTM | 2,551 |
CFO 3Y Avg | 1,863 |
Growth & Margins
Median | |
---|---|
Name | |
Rev Chg LTM | 5.0% |
Rev Chg 3Y Avg | 2.2% |
Rev Chg Q | 5.8% |
QoQ Delta Rev Chg LTM | 1.4% |
Op Mgn LTM | 19.7% |
Op Mgn 3Y Avg | 19.9% |
QoQ Delta Op Mgn LTM | -0.2% |
CFO/Rev LTM | 23.0% |
CFO/Rev 3Y Avg | 21.7% |
FCF/Rev LTM | 14.6% |
FCF/Rev 3Y Avg | 12.8% |
Valuation
Median | |
---|---|
Name | |
Mkt Cap | 40.0 |
P/S | 5.3 |
P/EBIT | 16.5 |
P/E | 25.1 |
P/CFO | 17.1 |
Total Yield | 3.0% |
Dividend Yield | 0.1% |
FCF Yield 3Y Avg | 1.8% |
D/E | 0.1 |
Net D/E | 0.0 |
Returns
Median | |
---|---|
Name | |
1M Rtn | -0.8% |
3M Rtn | 16.0% |
6M Rtn | 4.1% |
12M Rtn | -14.3% |
3Y Rtn | -7.6% |
1M Excs Rtn | -3.2% |
3M Excs Rtn | 5.9% |
6M Excs Rtn | -13.1% |
12M Excs Rtn | -32.6% |
3Y Excs Rtn | -77.9% |
Comparison Analyses
Returns Analyses
Earnings Returns History
Expand for MoreForward Returns | |||
---|---|---|---|
Earnings Date | 1D Returns | 5D Returns | 21D Returns |
8/27/2025 | -12.9% | -8.2% | |
5/29/2025 | -14.6% | -11.0% | -11.0% |
3/6/2025 | -6.6% | -14.6% | -18.9% |
12/5/2024 | -4.4% | -6.3% | -10.2% |
8/28/2024 | 11.8% | 12.7% | 16.1% |
5/30/2024 | 4.5% | 5.6% | -4.3% |
2/29/2024 | 9.2% | 9.1% | 6.0% |
12/7/2023 | -2.9% | 6.5% | 7.6% |
... | |||
SUMMARY STATS | |||
# Positive | 13 | 13 | 13 |
# Negative | 11 | 11 | 11 |
Median Positive | 4.4% | 5.6% | 7.0% |
Median Negative | -3.1% | -7.6% | -10.3% |
Max Positive | 11.8% | 12.7% | 16.1% |
Max Negative | -14.6% | -14.6% | -18.9% |
SEC Filings
Expand for MoreReport Date | Filing Date | Filing |
---|---|---|
7312025 | 8282025 | 10-Q 7/31/2025 |
4302025 | 5302025 | 10-Q 4/30/2025 |
1312025 | 3072025 | 10-Q 1/31/2025 |
10312024 | 12062024 | 10-K 10/31/2024 |
7312024 | 8292024 | 10-Q 7/31/2024 |
4302024 | 5312024 | 10-Q 4/30/2024 |
1312024 | 3012024 | 10-Q 1/31/2024 |
10312023 | 12082023 | 10-K 10/31/2023 |
7312023 | 8312023 | 10-Q 7/31/2023 |
4302023 | 6022023 | 10-Q 4/30/2023 |
1312023 | 3032023 | 10-Q 1/31/2023 |
10312022 | 12092022 | 10-K 10/31/2022 |
7312022 | 9012022 | 10-Q 7/31/2022 |
4302022 | 6032022 | 10-Q 4/30/2022 |
1312022 | 3042022 | 10-Q 1/31/2022 |
10312021 | 12102021 | 10-K 10/31/2021 |
External Quote Links
Y Finance | Barrons |
TradingView | Morningstar |
SeekingAlpha | ValueLine |
Motley Fool | Robinhood |
CNBC | Etrade |
MarketWatch | Unusual Whales |
YCharts | Perplexity Finance |
FinViz |